NDC 29033-056
Metformin Hydrochloride 750 mg tablet, extended release
On the label: Nostrum Laboratories, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Nostrum Laboratories, Inc. | Bryan, Ohio, United States | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyMar 13, 2025 · 6 inspections |
Recalls
- Jan 25, 2021 · Class II · Nostrum Laboratories Inc
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.
Lots: Lot MET200601, 07/2022 - Jan 4, 2021 · Class II · Nostrum Laboratories Inc
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level
Lots: MET200501 07/2022 - Oct 23, 2020 · Class II · Nostrum Laboratories Inc
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level
Lots: MET200101, MET200301 EXP 05/2022
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Metformin: every company that makes it
- Form
- tablet, extended release
- Strength
- 750 mg
- Approval
- ANDA ANDA076756
- On the market since
- Aug 6, 2020
- Package NDCs
29033-056-0129033-056-10- Official label
- DailyMed (National Library of Medicine), updated Nov 26, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?